New
Image

23.06.2025
NICE approves tirzepatide (Mounjaro) for treating obesity but access t...
NICE (the National Institute for Health and Care Excellence) have now approved tirzepatide (also known by...
customer support
customer support
We take a look at some of the exciting diabetes research developments announced in May, including how the long-term benefits of weight loss and metformin could slow type 2 diabetes progression, and how continuous glucose monitoring could protect the heart health of people with type 1 diabetes.
Read more